Zeki Ilkan, PhD

Business Development Scientist with 10+ years of experience spanning drug discovery, pharmacology, ion channel electrophysiology, and cardiovascular research. I combine deep scientific expertise with commercial strategy to help pharmaceutical and biotechnology companies design effective preclinical drug discovery programmes that deliver both scientific excellence and commercial value. In my current role at Metrion Biosciences, I work closely with clients to understand their scientific objectives, develop tailored study proposals, and provide strategic support throughout the business development process. I enjoy building relationships with scientists and industry partners, translating complex scientific concepts into practical solutions, and contributing to business growth by aligning high-quality science with commercial objectives. Prior to moving into commercial operations, I established a strong research career through doctoral and postdoctoral training at Mount Sinai Hospital (New York) and the University of Oxford, developing expertise in cardiovascular pathophysiology, pharmacology, neuronal physiology, and preclinical drug discovery. My research has resulted in numerous peer-reviewed publications in high-impact journals. My career has allowed me to bridge the gap between science and business, combining scientific credibility with client-focused communication, strategic thinking, and commercial awareness. I am passionate about supporting innovation in drug discovery and building long-term partnerships that help bring new therapies closer to patients. Core expertise includes: - Drug discovery & preclinical research - Cardiovascular pharmacology & physiology - Ion channel electrophysiology - CRO operations & client-facing scientific support - Scientific proposal development & study design - Translational biomedical research